Injective targets $60 as new MACD crossover and AI pilot drive momentum

Injective (INJ) is building renewed bullish momentum following a significant breakout from its prior accumulation phase. A fresh MACD crossover lends additional technical strength, while recent developments in real-world asset (RWA) tokenization and artificial intelligence integration are reinforcing Injective’s role in the evolving digital financial sector. Technical momentum and resistance levels INJ has recently exited a prolonged consolidation zone after moving between approximately $3.80 and $5.00, with price advancing to a peak near $8.25 before consolidating around $7.79. The token consistently trades above its main exponential moving averages, and the 20-day EMA located at $6.06 is emerging as a crucial support area in the event of short-term declines. Momentum indicators remain robust. The Relative Strength Index is currently measured at 70.80, above its moving average of 62.57, underscoring persistent buyer interest. However, this high RSI reading also brings INJ close to overbought territory, raising the possibility of near-term consolidation before any further sustained rally. Crypto analyst JAVON MARKS highlighted that INJ gained about 53% since a previous bullish MACD crossover. He identified a new crossover forming, pointing to further upside toward a $60 target. MARKS noted that a historical crossover preceded a rally of over 3,300%, although he advised that such past performance does not guarantee a repetition. MARKS suggested, “A fresh MACD crossover could open the path toward the $60 objective if bullish momentum holds and critical support levels are preserved.” Support at $7.40 remains essential for bulls aiming to maintain the breakout. A potential breach could push INJ down to the 50-day EMA near $5.51, with traders monitoring these areas for confirmation that the broader structure remains intact. Level Approximate Value Significance Short-term support (20-day EMA) $6.06 Dynamic support; near-term pullback zone Critical support zone $7.40 Holds bullish momentum above breakout Major support (50-day EMA) $5.51 Potential downside target if $7.40 fails Upside target $60.00 Longer-term technical objective AI initiatives and RWA tokenization pilot Beyond technical trends, Injective is advancing its position in the sector through RWA infrastructure development, institutional-grade adoption, and AI-driven financial applications. The network is building a platform that combines asset issuance, trading, settlement, compliance, recordkeeping, and AI-based operations into an on-chain ecosystem. Recently, Injective launched a pilot related to trade finance, in collaboration with POSCO International and LG CNS. This initiative involved automating on-chain transactions using trade receivables derived from actual business operations. Artificial intelligence agents checked letters of credit and trade documents, while the receivables themselves were issued as permissioned tokens. Mini dictionary: POSCO International and LG CNS are major South Korean companies. POSCO International operates in steel trading and resources, while LG CNS is an IT services and solutions provider. Their collaboration with Injective highlights cross-industry applications for blockchain finance and AI.